Washington, D.C. – On Thursday, June 29, thought leaders from across the cancer community gathered in the nation’s capital to explore solutions that foster continued innovation and deliver better outcomes for patients. Co-hosted by the Personalized Medicine Coalition (PMC), the American Association for Cancer Research (AACR), Feinstein Kean Healthcare (FKH), and CancerCare, the third national conference of the Turning the Tide Against Cancer Through Sustained Medical Innovation initiative brought together stakeholders from the scientific, clinical, regulatory, industry, and patient advocacy communities to participate in solutions-oriented discussions that delineate strategies for policymakers to consider that support meaningful patient engagement and deliver value to patients.
“Regarding the critical issues of clinical decision-making and reimbursement, the Turning the Tide initiative reminds us again that the patient voice must be right front and center in the cancer research and care process,” said Edward Abrahams, PhD, president, PMC. “In order to realize the benefits of personalized medicine — which represents the future of oncology — and address the rising cost of cancer care, patients must be active participants in treatment decision-making.”
Ahead of the fifth anniversary of the Turning the Tide Against Cancer initiative, which first convened in 2012, PMC, the AACR, and FKH convened an expert working group of top leaders in cancer research, health care policy, and patient advocacy to explore the shift from volume to value-based care and how this may affect whether clinical pathways are effectively facilitating patient access to high-quality and high-value care. Results from the expert working group, published this week in the journal Clinical Cancer Research suggest that a lack of accountability exists across the continuum of a pathway, leading to the group’s recommendation that an independent third party serve in an accreditation or oversight capacity for these tools. The manuscript, Clinical Pathways: Recommendations for Putting Patients at the Center of Value-Based Care, places the patient at the forefront of the discussion around cancer care, a necessary concept and central theme of Turning the Tide.
"It is an amazing time in the field of oncology," said Margaret Foti, PhD, MD (hc), chief executive officer of the AACR. "Scientific data is being collected, shared, and utilized in more productive ways than ever before, and cancer patients are finding it easier to search for and enroll in a cancer clinical trial than at any time in our nation's history. Discussions during today's conference will help catalyze a new phase of community-wide action to ensure that cancer patients' voices become an even more integral part of the cancer research and care delivery processes."
“We are positioned at a unique convergence in health care, with the influx of scientific innovation, health data, and patient engagement driving a shift to value-based care,” said Marcia Kean, MBA, chairman, Strategic Initiatives, FKH. “It is our collective responsibility to incorporate the patient perspective as we develop new health care delivery models so that we can align patient priorities and preferences with available scientific evidence to drive appropriate treatment decisions.”
At the Turning the Tide Against Cancer 2017 National Conference, experts working in oncology innovation and healthcare policy gathered for a dialogue featuring a full patient panel to open and close the event, and an extensive lineup of speakers dedicated to finding solutions that drive patient-centered care.
“It’s time for patient-centered care to be the standard of care,” said Patricia Goldsmith, chief executive officer, CancerCare. “Progress toward this requires partnerships across industry, policy, and advocacy to catalyze broad community action to ensure that the patient’s voice is an integral part of the cancer research and care system. Through the Turning the Tide Against Cancer 2017 National Conference and in the coming years, we remain committed to fulfilling this goal.”
Information about the Turning the Tide Against Cancer 2017 National Conference
The one-day program included interactive panels, spotlight sessions, and a keynote presentation by Joan Lunden, former host of Good Morning America, journalist, author, patient advocate and breast cancer survivor, to discuss value, innovation, and patient access and how these key areas of concern render meaningful patient engagement more necessary in cancer research and delivery of care.
To view the full event schedule and a live webcast, visit www.TurningTheTideAgainstCancer.org.
Be part of the conversation on Twitter by using the hashtag #T3Cancer.